Skip to main content

Table 4 Doses that yielded the best overall responses

From: Phase I dose-finding study of cabazitaxel administered weekly in patients with advanced solid tumours

  Best overall responsea
Planned dose level, mg/m2 Investigator’s response Response review meeting (expert) Final evaluation
8.4 PR PR PR
PR NC NC
10 NCb NCc NC c
12 PR PR PR
  1. a Each response represents one patient. b CR at cycle 2. c PR at cycle 2.
  2. CR complete response, PR partial response, NC no change.